CTIS2024-513846-13-00进行中（未招募）1 期
Aspirin in immune thrombocytopenia patients with cardiovascular disease - RC31/19/0509
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •adult patients (sup 18-year-old), non-treated ITP or ITP with stable treatment (at least 1 month), treated with aspirin daily for a cardiovascular disease, stable platelet count < 100 x 109/L, at least one month following an arterial thrombosis; no other antiplatelet drug, female patient with childbearing potential must have acceptable method of birth control, affiliated or benefiting from public health insurance.
排除标准
- •opposition to participate, adults Under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision, pregnancy or breastfeeding
研究者
相似试验
进行中（未招募）
1 期
ASPirin in Immune thRombocytopenia patientsImmune thrombocytopenia with cardiovascular diseaseMedDRA version: 23.0Level: PTClassification code 10083842Term: Immune thrombocytopeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2020-000968-30-FRCHU Toulouse10
招募中
1 期
Treatment of severe immune thrombocytopenia with hormone resistance by combination of traditional Chinese and Western MedicineImmune thrombocytopeniaITMCTR2000003847Shanghai Hospital of Traditional Chinese Medicine
未知
3 期
Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective ProcedureThrombocytopenia Associated With Chronic Liver DiseaseJPRN-jRCT2080222694Eisai Co., Ltd.300
已完成
2 期
ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEasePurpura, ThrombocytopenicNCT04912505University Hospital, Toulouse4
撤回
不适用
Immune ThrombocytoPenia * Before and After Therapy studyIdiopathic Thrombocytopenic PurpuraITP1003553410003816NL-OMON38836Sanquin Bloedbank60